Previous close | 106.72 |
Open | 105.16 |
Bid | 103.66 x 20000 |
Ask | 104.42 x 20000 |
Day's range | 105.16 - 105.82 |
52-week range | 71.33 - 131.88 |
Volume | |
Avg. volume | 53 |
Market cap | 42.083B |
Beta (5Y monthly) | 1.22 |
PE ratio (TTM) | 73.49 |
EPS (TTM) | 1.44 |
Earnings date | 25 Jul 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 530.60 |
Key Insights Using the 2 Stage Free Cash Flow to Equity, DexCom fair value estimate is US$113 DexCom's US$113 share...
Smart rings and smartwatches are providing consumers with reams of health information. Clinical device makers like DexCom needn’t worry.
We recently compiled a list of the 10 Best Growth Stocks To Buy Now According To Billionaire Ray Dalio. In this article, we are going to take a look at where DexCom, Inc. (NASDAQ:DXCM) stands against the other growth stocks. Ray Dalio is one of the most successful investors in Wall Street’s history. He has […]